<DOC>
	<DOCNO>NCT01426594</DOCNO>
	<brief_summary>This Phase 4 , observational , open study patient doctor prescribe METPURE XL ( S ( - ) metoprolol succinate ) clinical practice . No medication provide sponsor . The planned observation time 8 week . The 8 week observation involve evaluation baseline follow information gather assessment visit week 4 week 8 .</brief_summary>
	<brief_title>Real-life Experience Use Isomers METPURE XL ( S ( - ) Metoprolol Succinate ) Evaluation Efficacy , Safety Tolerability Management Cardiovascular Disease Colombian Patients</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Patients prescibed ( ) metoprolol succinate ( 25mg , 50mg ) , depend clinical condition use locally approve eligible participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Observational</keyword>
	<keyword>Colombia</keyword>
	<keyword>Metpure XL</keyword>
</DOC>